Success Metrics

Clinical Success Rate
100.0%

Based on 10 completed trials

Completion Rate
100%(10/10)
Active Trials
1(8%)
Results Posted
30%(3 trials)

Phase Distribution

Ph not_applicable
2
15%
Ph phase_2
1
8%
Ph phase_1
1
8%
Ph phase_3
3
23%
Ph phase_4
6
46%

Phase Distribution

1

Early Stage

1

Mid Stage

9

Late Stage

Phase Distribution13 total trials
Phase 1Safety & dosage
1(7.7%)
Phase 2Efficacy & side effects
1(7.7%)
Phase 3Large-scale testing
3(23.1%)
Phase 4Post-market surveillance
6(46.2%)
N/ANon-phased studies
2(15.4%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

90.9%

10 of 11 finished

Non-Completion Rate

9.1%

1 ended early

Currently Active

1

trials recruiting

Total Trials

13

all time

Status Distribution
Active(1)
Completed(10)
Terminated(1)
Other(1)

Detailed Status

Completed10
unknown1
Withdrawn1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
13
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (7.7%)
Phase 21 (7.7%)
Phase 33 (23.1%)
Phase 46 (46.2%)
N/A2 (15.4%)

Trials by Status

unknown18%
withdrawn18%
completed1077%
recruiting18%

Recent Activity

1 active trials
Showing 5 of 13
recruitingphase_2

Efficacy of Human Chorionic Gonadotropin in Acute GVHD Treatment

NCT06904599
completednot_applicable

HUMAN CHORIONIC GONADOTROPIN (HcG) VS MAGNESIUM SULPHATE (MgSo4) AS A TOCOLYTIC AGENT- A RANDOMIZED CONTROLLED TRIAL

NCT05828966
completedphase_4

Effect of GnRH Agonist vs GnRH Antagonist on IVF/ICSI Outcomes in Polycystic Ovary Syndrome Patients.

NCT04727671
completedphase_4

Effect of GnRH Agonist vs GnRH Antagonist on Oocyte Morphology During IVF/ICSI

NCT04724486
completedphase_4

Effect of GnRH Agonist vs GnRH Antagonist on IVF/ICSI Outcomes.

NCT04724343
View all 13 trials

Clinical Trials (13)

Showing 13 of 13 trials
NCT06904599Phase 2

Efficacy of Human Chorionic Gonadotropin in Acute GVHD Treatment

Recruiting
NCT05828966Not Applicable

HUMAN CHORIONIC GONADOTROPIN (HcG) VS MAGNESIUM SULPHATE (MgSo4) AS A TOCOLYTIC AGENT- A RANDOMIZED CONTROLLED TRIAL

Completed
NCT04727671Phase 4

Effect of GnRH Agonist vs GnRH Antagonist on IVF/ICSI Outcomes in Polycystic Ovary Syndrome Patients.

Completed
NCT04724486Phase 4

Effect of GnRH Agonist vs GnRH Antagonist on Oocyte Morphology During IVF/ICSI

Completed
NCT04724343Phase 4

Effect of GnRH Agonist vs GnRH Antagonist on IVF/ICSI Outcomes.

Completed
NCT04727684Phase 4

Effect of GnRH Agonist vs GnRH Antagonist on Oocyte Morphology in Polycystic Ovary Syndrome Patients During IVF/ICSI

Completed
NCT04071574Phase 1

Comparative Study on the Efficacy of Ovarian Stimulation Protocols on the Success Rate of ICSI in Female Infertility

Completed
NCT01599494Phase 3

An Efficacy and Safety Study of Corifollitropin Alfa (MK-8962) in Contrast to Recombinant FSH for Use in Controlled Ovarian Stimulation of Indian Women (P07056, Also Known as MK-8962-029)

Withdrawn
NCT01786252Phase 4

Effect of hCG on Receptivity of the Human Endometrium

Completed
NCT01863680Phase 3

Phase 3 Trial to Evaluate the Efficacy and Safety of COL-1620 Vaginal Progesterone Gel

Completed
NCT02329197Phase 4

Intrauterine Injection of Human Chorionic Gonadotropin Before Embryo Transfer in Women With Previous IVF Failure

Unknown
NCT01084265Phase 3

A Study Using Recombinant Human Luteinizing Hormone (r-hLH, Luveris®) in the Treatment of Chinese Women With Hypogonadotropic Hypogonadism

Completed
NCT00223860Not Applicable

Provocative Testing Using LHRH and hCG of the Pituitary-Gonadal Axis in Persons With Spinal Cord Injury.

Completed

All 13 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
13